Bioxytran presented four key Areas of Interest (AOI): an influenza antiviral, immune modulators for lung repair, solutions for uncontrolled hemorrhaging, and a versatile strategic therapeutic. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback